Immunotherapy resistance in NASH-HCC is driven by the dysfunctional liver microenvironment of NASH

被引：0
|
作者：
Geh, Daniel [1 ]
Gil, Erik Ramon [1 ]
Laszczewska, Maja [1 ]
Collins, Amy [1 ]
Luli, Saimir [1 ]
Cameron, Rainie [1 ]
Oakley, Fiona [1 ]
Leslie, Jack [1 ]
Reeves, Helen Louise [2 ,3 ]
Mann, Derek A. [1 ]
机构：
[1] Newcastle Univ, Newcastle Fibrosis Res Grp, Biosci Inst, Fac Med Sci, Newcastle, NSW, Australia
[2] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Newcastle, NSW, Australia
[3] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp Hepatopancreatobiliary Multidiscipli, Newcastle, NSW, Australia
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-234
引用
收藏
页码：S538 / S539
页数：2
相关论文
共 50 条
  • [1] The paradox of immunotherapy in NASH-HCC
    Yao Peng
    Chi Chun Wong
    Jun Yu
    Signal Transduction and Targeted Therapy, 6
  • [2] The paradox of immunotherapy in NASH-HCC
    Peng, Yao
    Wong, Chi Chun
    Yu, Jun
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [3] The role of hepatocyte TAZ in NASH and NASH-HCC
    Wang, Xiaobo
    Schwabe, Robert
    Tabas, Ira
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [4] Molecular landscape of NASH-HCC
    Jordan Hindson
    Nature Reviews Gastroenterology & Hepatology, 2021, 18 : 456 - 456
  • [5] CXCR2 inhibition sensitises NASH-HCC to immunotherapy
    Leslie, Jack
    Mackey, John B. G.
    Jamieson, Thomas
    Reeves, Helen L.
    Llovet, Josep M.
    Leo, Carlin
    Bird, Thomas G.
    Sansom, Owen
    Mann, Derek A.
    JOURNAL OF HEPATOLOGY, 2022, 77 : S385 - S386
  • [6] Molecular landscape of NASH-HCC
    Hindson, Jordan
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2021, 18 (07) : 456 - 456
  • [7] CXCR2 inhibition enables NASH-HCC immunotherapy
    Leslie, Jack
    Mackey, John B. G.
    Jamieson, Thomas
    Ramon-Gil, Erik
    Drake, Thomas M.
    Fercoq, Frederic
    Clark, William
    Gilroy, Kathryn
    Hedley, Ann
    Nixon, Colin
    Luli, Saimir
    Laszczewska, Maja
    Pinyol, Roser
    Esteban-Fabro, Roger
    Willoughby, Catherine E.
    Haber, Philipp K.
    Andreu-Oller, Carmen
    Rahbari, Mohammad
    Fan, Chaofan
    Pfister, Dominik
    Raman, Shreya
    Wilson, Niall
    Muller, Miryam
    Collins, Amy
    Geh, Daniel
    Fuller, Andrew
    McDonald, David
    Hulme, Gillian
    Filby, Andrew
    Cortes-Lavaud, Xabier
    Mohamed, Noha-Ehssan
    Ford, Catriona A.
    Iraolagoitia, Ximena L. Raffo
    McFarlane, Amanda J.
    McCain, Misti, V
    Ridgway, Rachel A.
    Roberts, Edward W.
    Barry, Simon T.
    Graham, Gerard J.
    Heikenwalder, Mathias
    Reeves, Helen L.
    Llovet, Josep M.
    Carlin, Leo M.
    Bird, Thomas G.
    Sansom, Owen J.
    Mann, Derek A.
    GUT, 2022, 71 (10) : 2093 - 2106
  • [8] T cell drivers in NASH-HCC
    O'Leary, Karen
    NATURE REVIEWS CANCER, 2021, 21 (06) : 341 - 341
  • [9] T cell drivers in NASH-HCC
    Karen O’Leary
    Nature Reviews Cancer, 2021, 21 : 341 - 341
  • [10] Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment
    Zhang, Peng
    Chen, Zhimin
    Kuang, Henry
    Liu, Tongyu
    Zhu, Jiaqiang
    Zhou, Linkang
    Wang, Qiuyu
    Xiong, Xuelian
    Meng, Ziyi
    Qiu, Xiaoxue
    Jacks, Ramiah
    Liu, Lu
    Li, Siming
    Lumeng, Carey N.
    Li, Qing
    Zhou, Xiang
    Lin, Jiandie D.
    CELL METABOLISM, 2022, 34 (09) : 1359 - +
12345